MFDX - ETF AI Analysis

Top Page

PIMCO RAFI Dynamic Multi-Factor International Equity ETF (MFDX)

Rating:64Neutral

Price Target:―

MFDX, the PIMCO RAFI Dynamic Multi-Factor International Equity ETF, earns a solid overall rating thanks to several high-quality international blue chips, especially Novartis and HSBC, which bring strong financial performance, positive earnings outlooks, and generally supportive technical trends. Other major positions like Roche, GlaxoSmithKline, and Nestlé add stability through solid cash flow and reasonable valuations, though some names such as BAE Systems and ENI face weaker technical signals or potential overbought conditions that slightly weigh on the fund. The main risk factor is its concentration in a relatively small set of large non-U.S. companies and sectors like pharmaceuticals, financials, and energy, which can expose investors to region- and sector-specific setbacks.

Positive Factors

Broad International Diversification

The fund spreads its investments across many countries, with meaningful exposure to Japan, the UK, Europe, and other regions, which helps reduce reliance on any single market.

Balanced Sector Mix

Holdings are spread across financials, industrials, consumer stocks, health care, and other sectors, which can help smooth out performance when one industry is struggling.

Generally Positive Recent Performance

The ETF has shown steady gains over the past month, three months, and year to date, indicating that its strategy has been working in the current market environment.

Negative Factors

Moderate Expense Ratio

The fund’s fee is not especially low for an ETF, which means a small but ongoing drag on returns compared with cheaper index funds.

Small Individual Position Sizes

Each top holding makes up less than 1% of the fund, so even strong performers like BAE Systems have only a limited impact on overall returns.

Mixed Performance Among Top Holdings

While several leading positions such as Novartis, Roche, HSBC, and BAE Systems have been strong, others like Nestlé and GSK have been weak, which can offset some of the gains.

MFDX vs. SPDR S&P 500 ETF (SPY)

AUM421.46M

RegionDeveloped Markets

Expense Ratio0.39%

Beta0.64

IssuerPIMCO

Inception DateAug 31, 2017

Dividend Yield2.84%

Asset ClassEquity

Index TrackedRAFI Dynamic Multi-Factor Developed Ex-U.S. Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume24,144

30 Day Avg. Volume27,908

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

44.81

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering1274

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

MFDX Summary

MFDX is an international stock ETF that follows the RAFI Dynamic Multi-Factor Developed Ex-U.S. Index, focusing on companies outside the United States. It owns a wide mix of businesses across many countries like Japan, the UK, and Europe, and across many sectors such as financials, industrials, and healthcare. Well-known holdings include Nestlé, Novartis, and HSBC. Investors might consider MFDX to diversify beyond U.S. stocks and seek long-term growth from global markets. A key risk is that international stock prices can be volatile and can go up or down with global market and currency swings.

How much will it cost me?The PIMCO RAFI Dynamic Multi-Factor International Equity ETF (MFDX) has an expense ratio of 0.39%, which means you’ll pay $3.90 per year for every $1,000 invested. This is slightly higher than average for ETFs because it uses an actively managed multi-factor strategy to adjust its portfolio dynamically, aiming to optimize performance and reduce risk.

What would affect this ETF?MFDX’s focus on developed international markets and multi-factor investing could benefit from global economic growth, particularly in sectors like Financials and Industrials, which are heavily weighted in the fund. However, challenges such as rising interest rates, geopolitical tensions, or regulatory changes in key regions could negatively impact its performance, especially for top holdings like banks or consumer-focused companies. Diversification across sectors and countries helps mitigate risks but does not eliminate them entirely.

MFDX Top 10 Holdings

MFDX is leaning heavily on Europe and other developed markets outside the U.S., with a clear tilt toward big banks and global healthcare giants. Drugmakers like Novartis, Roche, and especially GSK are doing the heavy lifting, with shares rising and giving the fund a healthy defensive backbone. On the financial side, Banco Santander, Societe Generale, and HSBC are also climbing, adding cyclical punch. Consumer staples such as Nestlé and Unilever are steady-to-rising ballast, while British American Tobacco and BAE Systems look more mixed, occasionally tugging at returns despite solid fundamentals.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
BATS	British American Tobacco	0.94%	$3.94M	£97.95B	42.78%	71 Outperform
NOVN	Novartis AG	0.92%	$3.87M	CHF230.97B	25.96%	80 Outperform
SAN	Banco Santander	0.83%	$3.47M	€139.93B	57.31%	73 Outperform
GSK	GlaxoSmithKline	0.80%	$3.36M	£81.32B	34.41%	77 Outperform
ROG	Roche Holding AG	0.76%	$3.20M	CHF256.31B	21.75%	73 Outperform
ENI	ENI S.p.A.	0.72%	$3.01M	€65.37B	63.86%	63 Neutral
BA	BAE Systems	0.71%	$3.00M	£67.25B	41.30%	61 Neutral
GLE	Societe Generale	0.71%	$2.98M	€41.51B	56.38%	72 Outperform
NESN	Nestlé SA	0.67%	$2.81M	CHF204.54B	-0.11%	71 Outperform
IBE	Iberdrola	0.64%	$2.68M	€132.28B	42.78%	67 Neutral

MFDX Technical Analysis

Technical Analysis Sentiment

Negative

Last Price―

Price Trends

50DMA

40.87

Negative

100DMA

39.27

Positive

200DMA

37.57

Positive

Market Momentum

MACD

-0.32

Positive

RSI

32.15

Neutral

STOCH

18.74

Positive

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For MFDX, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 41.64, equal to the 50-day MA of 40.87, and equal to the 200-day MA of 37.57, indicating a neutral trend. The MACD of -0.32 indicates Positive momentum. The RSI at 32.15 is Neutral, neither overbought nor oversold. The STOCH value of 18.74 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MFDX.

MFDX Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
MFDX	―	―	$421.46M	0.39%	64 Neutral
DFSI	―	―	$974.24M	0.24%	64 Neutral
SEIE	―	―	$953.84M	0.50%	63 Neutral
IDHQ	―	―	$655.78M	0.29%	64 Neutral
TLTD	―	―	$606.54M	0.39%	64 Neutral
FYLD	―	―	$594.27M	0.59%	60 Neutral

Performance Comparison

MFDX

PIMCO RAFI Dynamic Multi-Factor International Equity ETF

40.12

7.96

24.75%

DFSI

Dimensional International Sustainability Core 1 ETF

―

SEIE

SEI Select International Equity ETF

―

IDHQ

Invesco S&P International Developed High Quality ETF

―

TLTD

FlexShares Morningstar Developed Markets ex-US Factor Tilt

―

FYLD

Cambria Foreign Shareholder Yield ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents